LegiList
Congress, Made Clear.
Congress
Disclosures
Insights
My LegiList
Support LegiList
Legislators
Bills
Laws
Committees
Campaign Finance
Lobbying
Analytics
Weekly Briefing
Congress
Legislators
Bills
Laws
Committees
Disclosures
Campaign Finance
Lobbying
Insights
Analytics
Weekly Briefing
My LegiList
Support LegiList
For past Congresses, use the Browse menu.
Home
›
Bills
›
HRES 242
›
Lobbying
HRES 242
116th Congress • 2019–2021 (Ended)
Affirming the importance of the Orphan Drug Act, celebrating the over 750 new orphan therapies approved since its creation, and recognizing the need to continue supporting research and development for rare diseases.
Full Bill Page
Lobbying Summary
Organizations below reported lobbying activity that included this bill as a disclosed issue. Expand to view filing details.
Loading filings…